Doug Bailey Appointed to Nemucore Board
1/14/2013
Read more

Doug Bailey Appointed to Nemucore Board 
3/14/2013
Read more

Grant Press Release
12/18/2013
Read more

NMI Appoints Dr. Barbara Davis as New Chief Scientific Officer and VP of Toxicology and Pathology
1/2/2014
Read more

Nemucore Medical Innovations Appoints Douglas G. Bailey to Board of Directors
2/4/2014
Read more

Nemucore Publishes Research Article, “Nanoemulsions in Translational Research”
3/12/2014
Read more

Nemucore Publishes Research Article “Development Of EGFR Targeted Nanoemulsion”
3/24/2014
Read more

Nemucore Medical Innovations Presents at 4th Annual CCNE National Cancer Institute Site Visit
3/25/2014
Read more

WPI Grants Provost Award to Student Team for Their Work at Nemucore Medical Innovations
5/21/2014
Read more

Nemucore Publishes Research Article on Development of Nanoemulsion for Ovarian Cancer
6/24/2014
Read more

Nemucore Medical Innovations, Inc. Appoints Bryan Costantino to Board of Directors
7/21/2014
Read more

Timothy Coleman, president and CEO, Nemucore Medical Innovations, Inc., Worcester
8/3/2014
Read  more

Nemucore Announces Publication in Pharmaceutical Research
3/17/2015
Read more

Medical Prognosis Institute and Nemucore Announce Strategic Partnership
6/1/2015
Read more

Nemucore Medical Innovations, Inc. Announces Election of Independent Director
6/8/2015
Read more

Nemucore Medical Innovations, Inc. Appoints Daniel E. Geffken as Interim Chief Financial Officer
6/15/2015
Read more

Nemucore raises the bar for biotech interns to produce results
6/25/2015
Read more

Central Massachusetts Health
9/21/2015
Read more

Nemucore Medical Innovations, Inc. to Present at the 14th Annual BIO Investor Forum
10/21/2015
Read more

Nemucore Medical Innovations to Present at the Applied Pharmaceutical Nanotechnology Conference
10/29/2015
Read more

Nemucore Medical Innovations Options Clinical-Stage Aurora Kinase Inhibitor GSK1070916 From Cancer Research Technology (CRT)
12/7/2015
Read more

Nemucore Medical Innovations Completes Series A Financing
12/7/2015
Read more

Nemucore Medical Innovations Announces Appointment of Dr. Michael V. Seiden to Its Board of Directors and Clinical Advisory Board
12/9/2015
Read more

Nemucore Medical Innovations Announces Licensing Agreement With Pfenex Inc. Enabling Manufacture of Anti-Cancer Therapeutic NMI-8000, the Biologically Active Form of Mullerian Inhibitory Substance (MIS)
12/14/2015
Read more

Nemucore Medical Innovations to Present at Needham & Company’s 15th Annual Healthcare Conference
4/5/2016
Read more

Peter S. Cohan: Nemucore contributes 1.1 % of Massachusetts Biomedical Initiatives’ economic impact
4/18/2016
Read more

Nemucore Medical Innovations Announces NMI-500 ACOG Poster Presentation
5/11/2016
Read more

Nemucore Medical Innovations Announces NMI-350 ACOG Poster Presentation
5/12/2016
Read more

Nemucore Medical Innovations Announces Appointment of Nicholas De Monico to its Board of Directors
5/16/2016
Read more